Associations of the Expression Levels and Risk Variants of CDKN2B‐AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer
Min‐Che Tung, Chia‐Yen Lin, Yu‐Ching Wen, Lun‐Ching Chang, Shun‐Fa Yang, Ming‐Hsien Chien · 2024
Read Associations of the Expression Levels and Risk Variants of CDKN2B‐AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer by Min‐Che Tung, Chia‐Yen Lin, Yu‐Ching Wen, Lun‐Ching Chang, Shun‐Fa Yang, Ming‐Hsien Chien (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11617473.txt.
Description
Min-Che Tung and five co-authors study a long noncoding RNA, a gene-like molecule that does not build proteins, and its link to prostate cancer risk and progression. Their study came out in 2024. Variants of this RNA have been tied to several cancers, but its role in prostate cancer was unclear.
The team compared nearly seven hundred patients with the same number of healthy controls, testing five variants. One variant stood out. Patients carrying its minor form were more likely to develop tumors with high Gleason grades, a score of how aggressive the cancer looks. Tissue data showed that carriers also produced more of the RNA in the prostate. Cancer atlas data linked higher RNA levels to larger tumors, spread to lymph nodes, and shorter time without progression.
Catalog record
| CREATOR | Min‐Che Tung, Chia‐Yen Lin, Yu‐Ching Wen, Lun‐Ching Chang, Shun‐Fa Yang, Ming‐Hsien Chien |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |